José Yesid Rodríguez

ORCID: 0000-0001-5035-5297
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Antifungal resistance and susceptibility
  • Fungal Infections and Studies
  • Antimicrobial Resistance in Staphylococcus
  • Burkholderia infections and melioidosis
  • Bacterial Identification and Susceptibility Testing
  • Streptococcal Infections and Treatments
  • Plant Pathogens and Fungal Diseases
  • Nail Diseases and Treatments
  • Subcritical and Supercritical Water Processes
  • Public Health and Environmental Issues
  • Chemical Looping and Thermochemical Processes
  • Bacillus and Francisella bacterial research
  • Poxvirus research and outbreaks
  • Pneumonia and Respiratory Infections
  • Antibiotic Use and Resistance
  • Infective Endocarditis Diagnosis and Management
  • Autoimmune and Inflammatory Disorders
  • Phytoplasmas and Hemiptera pathogens
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Entomopathogenic Microorganisms in Pest Control
  • Infectious Diseases and Mycology
  • Dermatological and COVID-19 studies
  • E-Learning and Knowledge Management
  • Acne and Rosacea Treatments and Effects
  • Soft tissue tumor case studies

Popular University of Cesar
2016-2025

Universidad Cooperativa de Colombia
2023

Secretaría de Salud de Bogotá
2023

Secretaria Municipal de Educação de São Paulo
2023

Universidad De Santander
2021-2022

Clínica Santa María
2017-2021

Universidad Nacional de Colombia
2007-2019

Fundación Universitaria Sanitas
2016-2019

CorpoGen (Colombia)
2019

Colombian Association of Surgery
2019

Candida auris has become a major health threat due to its transmissibility, multidrug resistance and severe outcomes. In case-control design, 74 hospitalised patients with candidemia were enrolled. total, 22 cases (29.7%) 52 controls (C. albicans, 21.6%; C. parapsilosis, tropicalis, glabrata, 1.4%) included analysed in this study. Risk factors, clinical microbiological characteristics outcomes of non-auris species (NACS) compared. Previous fluconazole exposure was significantly higher (OR...

10.3390/jof9040430 article EN cc-by Journal of Fungi 2023-03-31

Candida auris is an emerging pathogen considered to be critical in the World Health Organization fungal organisms list. The study aims determine mortality and hospital stays attributed (C. auris) compared other species adult patients with candidemia. A retrospective cohort of adults candidemia was examined from seven centres Colombia between 2016 2021. primary outcome 30-day mortality, secondary length stay among survivors. Adjustment confounding variables performed using inverse probability...

10.3390/jof9070715 article EN cc-by Journal of Fungi 2023-06-29

Abstract Background Colombia has been endemic for KPC decades, mainly due to the clonal dissemination of blaKPC-3 among carbapenemase-producing K. pneumoniae (CP-Kp) sequence type (ST) 258 and plasmid blaKPC-2 different species Gram-negatives. However, a recent surge in detection blaNDM CP-Kp raised concerns. Herein, we aimed understand dynamics transmission carbapenemase genes clinical isolates two cities Colombia.Fig. 1.Molecular characterization 31 collected between 2018 - 2019.MLST:...

10.1093/ofid/ofae631.1534 article EN cc-by Open Forum Infectious Diseases 2025-01-29

Abstract Background Candida auris is an emerging MDR pathogen. It shows reduced susceptibility to azole drugs and, in some strains, high amphotericin B MICs have been described. For these reasons, echinocandins were proposed as first-line treatment for C. infections. However, information on how and act against this species lacking. Objectives Our aim was establish the killing kinetics of anidulafungin, caspofungin by time–kill methodology determine if antifungals behave fungicidal or...

10.1093/jac/dkz178 article EN Journal of Antimicrobial Chemotherapy 2019-05-07

Abstract Background First-line antifungal treatment for invasive mucormycosis (IM) consists of liposomal amphotericin B. Salvage options are limited and often based on posaconazole oral suspension. With the approval new formulations, patients could benefit from improved pharmacokinetics, safety tolerability. Objectives Our aim was to assess effectiveness formulations IM treatment. Methods We performed a case-matched analysis with proven or probable FungiScope® Registry. (1st-POSnew)...

10.1093/jac/dkz344 article EN Journal of Antimicrobial Chemotherapy 2019-07-16

Candida auris, first described in 2009, is an opportunistic pathogenic yeast that causes nosocomial outbreaks around the world, with high mortality rates associated therapeutic failure. In this study, we evaluated pathogenicity of 107 isolates from two cities Colombia, fungemia or colonization processes; to achieve this, used Galleria mellonella invertebrate model compare pathogenicity. Our results showed less than half total C. auris presented a compared reference strain SC5314, and most...

10.3390/jof7060401 article EN cc-by Journal of Fungi 2021-05-21

Colombia is the fifth most affected country by global monkeypox outbreak and second in LAC after Brazil. We describe clinical epidemiological characteristics of 521 patients with mpox country.We conducted an observational analysis laboratory-confirmed Mpox cases between June 29 November 16, 2022.Most were young men living HIV. The evolution was primarily benign, two deaths reported. found some differences women regarding their BMI, presence lymphadenopathies, localization lesions, antecedent...

10.1016/j.tmaid.2023.102594 article EN cc-by Travel Medicine and Infectious Disease 2023-05-01

10.1016/j.jinf.2020.08.015 article EN Journal of Infection 2020-08-13

ObjectivesMethicillin-resistant Staphylococcus aureus (MRSA) skin and soft tissue infections (SSTIs) represent a major clinical problem in Colombia. The aim of this study was to evaluate the risk factors associated with MRSA SSTI Colombia.MethodsA multicenter cohort nested case–control design performed. Patients an at least 48 h inpatient care were included. considered case group patients either non-MRSA or Methicillin-susceptible S. (MSSA) control groups. A multivariate logistic regression...

10.1016/j.ijid.2019.07.007 article EN cc-by-nc-nd International Journal of Infectious Diseases 2019-07-19

Las infecciones de piel y tejidos blandos (IPTB) representan la tercera causa consulta por enfermedad infecciosas a los servicios médicos, después las respiratorias urinarias. Se presenta una guía práctica clínica (GPC) con 38 recomendaciones basadas en evidencia, graduadas bajo el sistema SIGN, para diagnóstico tratamiento pacientes adultos IPTB contexto colombiano, posterior un proceso adaptación GPC publicadas búsqueda sistemática síntesis literatura actualización evidencia científica....

10.22354/in.v23i4.805 article ES Infectio 2019-09-09

Mucormycosis caused by Apophysomyces variabilis is rarely reported in humans. A case of A. infection an immunocompetent men after friction burns a car accident described. The presented as rapidly progressive necrotizing the skin and soft tissue, which required extensive surgical debridement total colonic defunctioning colostomy associated with prolonged antifungal therapy. should be considered differential diagnosis tissue infections individuals.

10.1016/j.mmcr.2017.12.002 article EN cc-by-nc-nd Medical Mycology Case Reports 2017-12-21

We report 7 cases of melioidosis in Colombia and comparision 4 commercial systems for identifying Burkholderia pseudomallei. Phoenix were not a definitive method B. For accurate identification, we recommend including this bacterium the library databases matrix-assisted laser desorption/ionization mass spectrometry Latin America.

10.3201/eid2508.170786 article EN cc-by Emerging infectious diseases 2019-06-20

Burkholderia pseudomallei is an emerging pathogen in the Americas. Cases of mother-to-child transmission B. are rare and probably occur by placental or perinatal infection. We report first case native gestational neonatal melioidosis Western hemisphere. The isolated strains mother newborn were confirmed whole-genome sequencing identified as a novel sequence type ST1748. comparison both genomes revealed nucleotide similarity 100%. Melioidosis should be considered within differential diagnosis...

10.4269/ajtmh.20-0223 article EN American Journal of Tropical Medicine and Hygiene 2020-08-04

Abstract We report an analysis of the genomic diversity isolates Burkholderia pseudomallei, cause melioidosis, recovered in Colombia from routine surveillance during 2016–2017. B. pseudomallei appears genetically diverse, suggesting it is well established and has spread across region.

10.3201/eid2702.202824 article EN Emerging infectious diseases 2021-01-14
Coming Soon ...